Data From a One-Stop-Shop Comprehensive Cancer Screening Center

Author:

Bernstein Ezra12ORCID,Lev-Ari Shahar13ORCID,Shapira Shiran13,Leshno Ari13,Sommer Udi4ORCID,Al-Shamsi Humaid5ORCID,Shaked Meital1,Segal Ori1ORCID,Galazan Lior1,Hay-Levy Mori1ORCID,Sror Miri1,Harlap-Gat Amira1ORCID,Peer Michael13,Moshkowitz Menachem13,Wolf Ido136,Liberman Eliezer13ORCID,Shenberg Gil1,Gur Eyal37,Elran Hanoch18,Melinger Gustavo39,Mashiah Jacob310,Isakov Ofer311,Zrifin Elad112,Gluck Nathan311,Dekel Roy311,Kleinman Shlomi312ORCID,Aviram Galit313,Blachar Arye313,Kessler Ada313,Golan Orit313,Geva Ravit36ORCID,Yossepowitch Ofer314,Neugut Alfred I.15ORCID,Arber Nadir1311

Affiliation:

1. Health Promotion and Integrated Cancer Prevention Center, Tel Aviv Medical Center, Tel Aviv, Israel

2. NYU Langone Medical Center, New York, NY

3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

4. Tel Aviv University Faculty of Social Sciences, School of Political Science, Government and International Relations, Tel Aviv, Israel

5. Burjeel Cancer Institute, University of Sharjah, Sharjah, United Arab Emirates

6. Department of Oncology, Tel Aviv Medical Center, Tel Aviv, Israel

7. Department of Plastic and Reconstructive Surgery, Tel Aviv Medical Center, Tel Aviv, Israel

8. Department of Neurosurgery, Tel Aviv Medical Center, Tel Aviv, Israel

9. The Gynecological and Obstetric Ultrasound Unit, Tel Aviv Medical Center, Tel Aviv, Israel

10. Division of Dermatology and Venerology, Tel Aviv Medical Center, Tel Aviv, Israel

11. Institute of Gastrointestinal and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel

12. Oral and Maxillofacial Surgery Unit, Otolaryngology-Head and Neck Surgery, Tel Aviv Medical Center, Tel Aviv, Israel

13. Department of Radiology, Tel Aviv Medical Center, Tel Aviv, Israel

14. Department of Urology, Tel Aviv Medical Center, Tel Aviv, Israel

15. Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY

Abstract

PURPOSE Cancer is the second leading cause of death globally. However, by implementing evidence-based prevention strategies, 30%-50% of cancers can be detected early with improved outcomes. At the integrated cancer prevention center (ICPC), we aimed to increase early detection by screening for multiple cancers during one visit. METHODS Self-referred asymptomatic individuals, age 20-80 years, were included prospectively. Clinical, laboratory, and epidemiological data were obtained by multiple specialists, and further testing was obtained based on symptoms, family history, individual risk factors, and abnormalities identified during the visit. Follow-up recommendations and diagnoses were given as appropriate. RESULTS Between January 1, 2006, and December 31, 2019, 8,618 men and 8,486 women, average age 47.11 ± 11.71 years, were screened. Of 259 cancers detected through the ICPC, 49 (19.8%) were stage 0, 113 (45.6%) stage I, 30 (12.1%) stage II, 25 (10.1%) stage III, and 31(12.5%) stage IV. Seventeen cancers were missed, six of which were within the scope of the ICPC. Compared with the Israeli registry, at the ICPC, less cancers were diagnosed at a metastatic stage for breast (none v 3.7%), lung (6.7% v 11.4%), colon (20.0% v 46.2%), prostate (5.6% v 10.5%), and cervical/uterine (none v 8.5%) cancers. When compared with the average stage of detection in the United States, detection was earlier for breast, lung, prostate, and female reproductive cancers. Patient satisfaction rate was 8.35 ± 1.85 (scale 1-10). CONCLUSION We present a proof of concept study for a one-stop-shop approach to cancer screening in a multidisciplinary outpatient clinic. We successfully detected cancers at an early stage, which has the potential to reduce morbidity and mortality as well as offer substantial cost savings. [Media: see text]

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Effects of aspirin on colon cancer using quantitative proteomic analysis;Cancer Pathogenesis and Therapy;2023-06

2. Shopping for New Cancer Screening Tests;Journal of Clinical Oncology;2023-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3